We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cooling Therapy for Heart Attack Patients

By HospiMedica staff writers
Posted on 09 Mar 2001
An ongoing clinical trial is investigating the feasibility of cooling therapy for heart attack patients. More...
The procedure is intended to reduce the injury caused by a heart attack by reducing the heart's need for oxygen and preventing cell death.

Dr. Robert Whitbourn of St. Vincent's Hospital (Melbourne, Australia) was the first to employ the cooling therapy to treat a heart attack patient. The treatment involves cooling the heart during and after an attack. A heat exchange catheter is placed in a large vein leading to the heart. The catheter cools the blood, which in turn cools the heart. The treatment was delivered by the SetPoint Endovascular Temperature Management System of Radiant Medical, Inc. (Redwood City, CA, USA).

The SetPoint System couples a heat exchange catheter with a microproccesor-controlled drive unit. The drive unit controls the temperature of the catheter and thus controls the temperature of the heart. The system offers rapid patient cooling or warming and precise maintenance of a target temperature. Radiant plans to enroll patients at major U.S. and international centers in this first phase of the study.

"The procedure went smoothly and according to plan and the patient is doing well,” said Dr. Whitbourn. "I am excited to be involved with this clinical trial. Therapeutic hypothermia has the potential to significantly improve outcomes for heart attack patients.”



Related Links:
Radiant Medical, Inc.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.